Sammamish, WA, United States of America

Mark L Bonyhadi

This inventor holds 13 USPTO granted patents and 16 published patent applications, plus 2 CIPO patents and 10 EPO patents. Top assignees: Juno Therapeutics Gmbh, Life Technologies Corporation, Xcyte Therapies, Inc.. Active years: 2004-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mark L Bonyhadi. Retrieved from https://idiyas.com/inventor/mark-l-bonyhadi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 

% Patents Active = 92.3

 

 

Average Co-Inventor Count = 4.7

ph-index = 9

Forward Citations = 1,288(Granted Patents)


Location History:

  • Issaquah, WA (US) (2004 - 2016)
  • Sammamish, WA (US) (2013 - 2023)

Company Filing History:


Years Active: 2004-2025

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Mark L Bonyhadi

Introduction

Mark L Bonyhadi is a prominent inventor based in Sammamish, WA (US), known for his significant contributions to the field of cell therapy and immunology. With a total of 13 patents to his name, Bonyhadi has made remarkable advancements in methods for isolating and genetically engineering immune cell populations.

Latest Patents

Among his latest patents is a method for isolating, culturing, and genetically engineering immune cell populations for adoptive therapy. This patent focuses on streamlined cell preparation methods that enhance the efficiency of isolating and processing immune cells, particularly T cells. Another notable patent is a process for generating therapeutic compositions of engineered cells, which provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. These methods include incubating cells under stimulating conditions and introducing recombinant polypeptides to promote cell proliferation.

Career Highlights

Throughout his career, Mark L Bonyhadi has worked with notable companies in the biotechnology sector, including Juno Therapeutics GmbH and Xcyte Therapies, Inc. His work has significantly impacted the development of innovative therapies aimed at treating various diseases through advanced cell engineering techniques.

Collaborations

Bonyhadi has collaborated with esteemed professionals in his field, including Dale Kalamasz and Ronald Jay Berenson. These collaborations have further enriched his research and contributed to the advancement of cell therapy.

Conclusion

Mark L Bonyhadi's innovative work in the field of immunology and cell therapy has led to significant advancements in the preparation and engineering of immune cells. His contributions continue to influence the development of effective therapeutic strategies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…